Amyloidosis and risk of psychiatric disorders-insights from a real-world nationwide registry
Authors:
- Wei-Syun HuWHWei-Syun Hu
- Po-Hsiang LiaoPLPo-Hsiang Liao
- Cheng-Li LinCLCheng-Li Lin
- Chih-Yang HuangCHChih-Yang Huang
Open Access
Abstract
No abstract availableKeywords
Funding Information
- China Medical University, Taiwan
- China Medical University (CMU112-ASIA-08)
This publication has 16 references indexed in Scilit:
- Transthyretin Amyloidosis: Update on the Clinical Spectrum, Pathogenesis, and Disease-Modifying TherapiesNeurology and Therapy, 2020
- Use of novel therapies in the treatment of light chain amyloidosisBlood Reviews, 2019
- Risk of new-onset atrial fibrillation among heart, kidney and liver transplant recipients: insights from a national cohort studyInternal and Emergency Medicine, 2018
- Association of anxiety with subcortical amyloidosis in cognitively normal older adultsMolecular Psychiatry, 2018
- Novel Therapies in Light Chain AmyloidosisKidney International Reports, 2018
- Role of CHA2DS2-VASc score in predicting new-onset atrial fibrillation in patients with type 2 diabetes mellitus with and without hyperosmolar hyperglycaemic state: real-world data from a nationwide cohortBMJ Open, 2018
- Stroke prediction with CHA2DS2-VASc score in patients with mesenteric ischemia without atrial fibrillation-insights from a nationwide cohortJournal of Clinical Neuroscience, 2017
- Postoperative ischemic stroke and death prediction with CHA 2 DS 2 -VASc score in patients having coronary artery bypass grafting surgery: A nationwide cohort studyInternational Journal of Cardiology, 2017
- Light-chain amyloidosis: SCT, novel agents and beyondBone Marrow Transplantation, 2012
- DOMINO HEPATIC TRANSPLANTATION USING THE LIVER FROM A PATIENT WITH FAMILIAL AMYLOID POLYNEUROPATHYTransplantation, 1998